Most Recent
Concrete repair company Vector Corrosion Technologies has lost its bid for ownership of a concrete treatment patent held by three former employees who jumped ship, with a court finding the trio invented the technology after leaving Vector.
National fitness chain F45 has appealed a court decision revoking two of its patents for a computer-run trainer workout system, arguing its system constituted a technological innovation in the field of fitness studio franchising which rival Body Fit has profited from.
A judge has signed off on a settlement in a trade mark spat between M&M candy maker Mars and the world's largest macadamia grower, Macquis Macadamias, under which Marquis will no longer seek to register its MM mark for chocolate bars.
Seven Network is in negotiations with Bangkok Broadcasting to resolve their spat over the Thai broadcaster's proposed 7HD trade mark, which was found to be deceptively similar to Seven's mark.
The High Court has decided to weigh in on whether computer-implemented inventions are eligible for patent protection, granting special leave to Aristocrat Technologies to challenge a judgment that shot down four patents for its popular Lightning Link electronic poker machine.
The High Court has found that Novartis unit Sandoz infringed Danish drug company Lundbeck's patent for its blockbuster antidepressant Lexapro, but has overturned a ruling that found the generic drug maker owes $26.3 million in damages.
Buy now, pay later giant Zip Co cannot rely on its infringing use of the 'Zip' trade mark to defend a lawsuit by the mark's owner Firstmac, the mortgage provider's barrister told a judge on the first day of trial in the high-stakes intellectual property dispute.
Online marketplace Redbubble cannot rely on the terms of a settlement with the US chapter of Hells Angels to avoid trade mark infringement claims by the Australian arm of the bikie gang, a court has ruled.
The maker of Mother brand energy drinks has filed an appeal challenging a judge's decision to remove two of its registered 'Mother' trade marks for non-use.
Bayer says the patents office was wrong to quash an extension for its patent covering an oral contraceptive on the grounds that its application should have been based on a drug with an earlier approval date.